The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
Checkpoint inhibitor therapy has introduced a revolution in contemporary anticancer therapy. It has led to dramatic improvements in patient outcomes and has spawned tremendous research into novel immunomodulatory agents and combination therapy that has changed the trajectory of cancer care. However,...
Main Authors: | David J. Hermel, Darren Sigal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4426/9/1/5 |
Similar Items
-
Progress of Biomarkers to Predict Response to Immune Checkpoint Inhibitors in Microsatellite Stability Colorectal Cancer
by: WANG Zhiqiang, et al.
Published: (2023-02-01) -
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
by: Annalice Gandini, et al.
Published: (2023-05-01) -
Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer
by: Chang Woo Kim, et al.
Published: (2021-09-01) -
The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
by: Kai Ding, et al.
Published: (2023-12-01) -
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
by: Javier Ros, et al.
Published: (2023-02-01)